Related Experiment Videos
Time dependency in plasmatic protein binding of cisplatin
Cancer Treatment Reports
|January 1, 1985
Summary
Cisplatin (a chemotherapy drug) protein binding in patient plasma exhibits a daily circadian rhythm, peaking around 4 PM. This time-dependent binding may influence drug efficacy and reduce toxicity when administered in the afternoon.
Area of Science:
- Pharmacology
- Chronobiology
- Oncology
Background:
- Cisplatin is a widely used chemotherapy agent.
- Understanding factors influencing cisplatin's pharmacokinetics is crucial for optimizing treatment.
- Circadian rhythms are known to affect various physiological processes, including drug metabolism.
Purpose of the Study:
- To investigate the time-of-day dependency of cisplatin binding to plasma proteins.
- To determine if cisplatin binding follows a circadian rhythm.
- To explore the potential impact of this rhythm on cisplatin's clinical effects, such as nephrotoxicity.
Main Methods:
- Plasma samples were collected from patients at multiple times throughout the day.
- The rate of cisplatin binding to plasma proteins was measured.
- Statistical analysis, including circadian rhythm analysis, was performed.
Main Results:
- Cisplatin binding to plasma proteins demonstrated a significant circadian rhythm, with an acrophase around 4 PM.
- The amplitude of this circadian variation was patient-dependent, averaging 11%.
- Plasma binding capacity was time-dependent, potentially influenced by circadian variations in total plasma protein concentration.
Conclusions:
- Cisplatin protein binding exhibits a circadian rhythm in patients.
- Faster binding in the afternoon may lead to lower free cisplatin levels, potentially contributing to reduced nephrotoxicity when administered at this time.
- Further research into chronotherapy with cisplatin is warranted.